Skip to main content
Janet Rubin, MD

It is amazing what UNC has accomplished during the past quarter to contribute to research, specifically on SARS-CoV-2; I’d particularly point to the very fine paper from UNC in Cell with department of medicine authors Alena Markmann, Luther Bartelt, David Margolis, and Rick Boucher (doi: 10.1016/j.cell.2020.05.042), among many others in print and press. We have every reason to be proud of our institution. Research continues to provide direct and indirect costs to the department of medicine.

  • Both clinical and bench research programs have been opening slowly, with strict regulations in place from the School of Medicine’s Office of Research.
  • The Department of Medicine now has an oversight committee to review inpatient COVID-19 clinical studies, thanks to Dr. Ann Lacheiwicz, Dr. Carrie Lee, and Ashwini Roy-Chaudhury, our director of clinical research.
  • Our faculty have contributed many hours toward reviewing COVID-19 grants and restarting human subjects protocols.
  • We know that our scientists are anxious to get back to their (non-COVID) work. Dr. Ron Falk and I would like to assure researchers that we are committed to support of research time.
  • Members of the Physician Scientist Training Program (PSTP) under Dr. Alex Duncan continue to meet regularly by Zoom, and we are welcoming two new scientists to the program: Dr. Jeff Jensen and Dr. Brooke Matson.
  • In addition, our K-grant writing group has moved along via Zoom, and is actively looking for faculty to participate. For more information, please contact Dr. Susan Hogan and Dr. Laura Loehr.
  • Both R-grant writing groups (Basic and Population Health) are also accepting applications, to start in August. For more information, please contact me at


Janet Rubin, MD,
Vice Chair for Research